Vaccinex Inc (VCNX)

Vaccinex Inc (VCNX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.8M; returns 1 day +6.2%, 1 week -29.9%, 1 year -20.3%.

Vaccinex Inc is a clinical-stage biotechnology company centered on the development of pepinemab (VX15/2503), a humanized monoclonal antibody designed to block Semaphorin 4D (SEMA4D). This target is a critical biological effector that triggers neuroinflammation via reactive gliosis in the brain and acts as an immune barrier in the tumor microenvironment.

Groups VCNX belongs to

• Biotechnology
• Clinical Stage Biotech
• Monoclonal Antibodies
• Alzheimer's Disease
• Neuroscience
• Oncology
• Drug Discovery
• Life Sciences
• Healthcare

VCNX financial model: income statement, cash flow and balance sheet